LATEST

Switzerland beat Colombia on penalties to reach quarter-finals●Watch every penalty from Switzerland v Colombia shootout●Arbeloa appointed new Fulham boss●Switzerland break Colombian hearts with first shoot-out success●Victims of 23andMe data breach to get $47m payout, judge rules●Jim Carrey Classic The Cable Guy Coming to 4K Ultra HD Steelbook●Reform asks NCA to investigate leaks of private financial information●Op-Ed: The New Theodore Roosevelt Library Is a Tribute to Conservation. Ironically, President Trump Was Its First Official Visitor.● Switzerland beat Colombia on penalties to reach quarter-finals●Watch every penalty from Switzerland v Colombia shootout●Arbeloa appointed new Fulham boss●Switzerland break Colombian hearts with first shoot-out success●Victims of 23andMe data breach to get $47m payout, judge rules●Jim Carrey Classic The Cable Guy Coming to 4K Ultra HD Steelbook●Reform asks NCA to investigate leaks of private financial information●Op-Ed: The New Theodore Roosevelt Library Is a Tribute to Conservation. Ironically, President Trump Was Its First Official Visitor.●

Longevity

A new off-ramp from Ozempic and Wegovy?

Longevity.Technology 15 June 2026, 16:41 UTC 15 Jun 2026

A new off-ramp from Ozempic and Wegovy? — Longevity.Technology

Fractyl Health reports one-year data suggesting patients may maintain weight loss after stopping GLP-1 drugs. Obesity medicine’s problem is not a weight-loss problem – that appears increasingly solvable thanks to blockbuster GLP-1 drugs such as Ozempic and Wegovy. The real challenge begins afterward. What happens when people stop taking them? For many patients, that’s not […] The post A new off-ramp from Ozempic and Wegovy? appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

More from Longevity

LG AI, D&D Pharmatech push AI-powered peptide drug discovery

Longevity.Technology · 7h ago

Rescuing Calcium Ion Homeostasis Extends Mouse Lifespan

Lifespan Research Institute · 8h ago

BioAge advances inflammaging drug into Phase 2

Longevity.Technology · 8h ago

AI-designed IPF drug advances to Phase III

Longevity.Technology · 11h ago

How Muscle Loss and Bone Loss Are Related

Lifespan Research Institute · 1d ago

RNA, AI and the end of one-size-fits-all nutrition

Longevity.Technology · 1d ago